
Anastomotic Leak Devices Market Report 2026
Global Outlook – By Usability (Disposable, Reusable), By Application (Gastrointestinal Surgery, Other Applications), By End-User (Hospitals, Speciality Clinics, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035
Anastomotic Leak Devices Market Overview
• Anastomotic Leak Devices market size has reached to $3.45 billion in 2025 • Expected to grow to $4.74 billion in 2030 at a compound annual growth rate (CAGR) of 6.5% • Growth Driver: Surge In Surgical Procedures Fuelling The Growth Of The Market Due To Rising Prevalence Of Chronic Diseases • Market Trend: Revolutionary 3D-Stapling Cutter Reduces Anastomotic Leaks And Enhances Surgical Safety • North America was the largest region in 2025.What Is Covered Under Anastomotic Leak Devices Market?
Anastomotic leak devices are medical tools or systems designed to detect, prevent, or manage leaks that occur at the surgical connection (anastomosis) between two hollow organs, such as parts of the intestine, after gastrointestinal surgery. These leaks can lead to serious complications, including infection and sepsis. The devices may include leak detection sensors, sealing materials, drainage systems, or stents that support healing and maintain the integrity of the anastomosis. The main usability of anastomotic leak devices includes disposable and reusable types. Disposable anastomotic leak devices are designed for one-time use during surgery and are discarded afterward. Their applications include cardiovascular surgery, gastrointestinal surgery, and others, serving a range of end-users, including hospitals, specialty clinics, and others.
What Is The Anastomotic Leak Devices Market Size and Share 2026?
The anastomotic leak devices market size has grown strongly in recent years. It will grow from $3.45 billion in 2025 to $3.68 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to limited availability of specialized leak detection devices, reliance on traditional surgical methods, increasing gastrointestinal and cardiovascular surgeries, rising awareness of post-operative complications, adoption of single-use surgical instruments.What Is The Anastomotic Leak Devices Market Growth Forecast?
The anastomotic leak devices market size is expected to see strong growth in the next few years. It will grow to $4.74 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to development of advanced reusable and disposable leak prevention devices, integration with smart surgical systems, rising hospital investments in patient safety technologies, growing demand for minimally invasive surgeries, expansion of specialty surgical clinics. Major trends in the forecast period include rising adoption of disposable surgical devices, integration of leak detection sensors in surgical procedures, increasing use of minimally invasive techniques, growing demand for gastrointestinal and cardiovascular surgeries, focus on post-surgical complication reduction and patient safety.Global Anastomotic Leak Devices Market Segmentation
1) By Usability: Disposable, Reusable 2) By Application: Gastrointestinal Surgery, Other Applications 3) By End-User: Hospitals, Speciality Clinics, Other End-Users Subsegments: 1) By Disposable: Single-Use Staplers, Disposable Sealants, Disposable Clips, Disposable Sutures, Disposable Leak Detection Sensors 2) By Reusable: Reusable Staplers, Reusable Clamps, Reusable Sealant Applicators, Reusable Leak Testing Devices, Reusable Surgical Instruments For Leak PreventionWhat Is The Driver Of The Anastomotic Leak Devices Market?
The growing number of surgical procedures is expected to propel the growth of the anastomotic leak devices market in the future. Surgical procedures are medical interventions that involve the use of instruments and manual techniques to treat injuries and diseases or improve bodily functions. The number of surgical procedures is growing due to advancements in minimally invasive technologies that make surgeries safer, less painful, and quicker to recover from, encouraging more patients and doctors to opt for surgical treatments. Anastomotic leak devices are helpful in surgical procedures by helping detect and manage leaks at the anastomosis site, reducing complications, and improving patient recovery. For instance, in May 2023, according to PubMed, a US-based biomedical literature database/research service, it was reported that on average, 877 surgeries were performed per 100,000 population. The proportion of cesarean sections was found to be high in all LMICs, with an average of 30.1% of the total surgeries, followed by hernia (16.4%) and laparotomy (5.1%). The overall surgical volumes increased as the GDP per capita increased. Therefore, the growing number of surgical procedures is driving the growth of the anastomotic leak devices industry.Key Players In The Global Anastomotic Leak Devices Market
Major companies operating in the anastomotic leak devices market are Johnson and Johnson, Medtronic plc, Boston Scientific Corporation, B Braun Melsungen AG, Ethicon Inc, Advanced Medical Solutions Group plc, Peters Surgical SAS, Dextera Surgical Inc, GT Metabolic Solutions Inc, Synovis Micro Companies Alliance Inc, CarpoNovum AB, Colospan Ltd, Exero Medical Ltd, Lydus Medical Ltd, Ovesco Endoscopy AG, Getinge AB, Olympus Medical Systems, Intuitive Surgical Inc, SurgiQuest Inc, AesDex LLCGlobal Anastomotic Leak Devices Market Trends and Insights
Major companies operating in the anastomotic leak devices market are focusing on developing innovative solutions, such as 3D surgical staplers, to improve surgical outcomes in complex procedures. A 3D surgical stapler is a device that uses advanced 3D-stapling technology to create staple lines with more uniform and even tissue compression. This technology is designed to distribute pressure across the tissue more effectively, reducing the risk of leaks or bleeding at the staple line. For instance, in May 2024, Ethicon Inc., a US-based medical equipment company, launched the ECHELON LINEAR Cutter, a first-of-its-kind surgical stapler that combines advanced 3D-stapling technology and gripping surface technology (GST) to deliver 47% fewer leaks at the staple line, helping reduce surgical risks. This innovative device allows surgeons greater control and flexibility by allowing the device halves to be locked or separated. It is designed to improve staple line integrity and consistency across various tissue types. The ECHELON LINEAR Cutter is the latest addition to Ethicon’s portfolio of colorectal surgical solutions. It is backed by clinical evidence demonstrating its effectiveness in reducing complications such as anastomotic leaks, which can lead to better patient outcomes and support safer surgical procedures.What Are Latest Mergers And Acquisitions In The Anastomotic Leak Devices Market?
In March 2024, Advanced Medical Systems Inc., a UK-based manufacturer of advanced wound care and wound closure products, acquired Peters Surgical for an undisclosed amount. With this acquisition, Advanced Medical Solutions aims to strengthen its position as a leading global specialist in tissue repair and skin closure by expanding its product portfolio, increasing direct sales capabilities, and broadening its global footprint through the complementary expertise and distribution networks of Peters Surgical. Peters Surgical is a France-based company that designs, manufactures, and distributes medical devices primarily used in surgical settings, including proximal anastomosis assist devices.Regional Outlook
North America was the largest region in the anastomotic leak devices market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Anastomotic Leak Devices Market?
The anastomotic leak devices market consists of sales of leak detection sensors, surgical sealants, intraluminal stents, tissue reinforcement materials, and leak closure devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Anastomotic Leak Devices Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $3.68 billion |
| Revenue Forecast In 2035 | $4.74 billion |
| Growth Rate | CAGR of 6.8% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Usability, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Johnson and Johnson, Medtronic plc, Boston Scientific Corporation, B Braun Melsungen AG, Ethicon Inc, Advanced Medical Solutions Group plc, Peters Surgical SAS, Dextera Surgical Inc, GT Metabolic Solutions Inc, Synovis Micro Companies Alliance Inc, CarpoNovum AB, Colospan Ltd, Exero Medical Ltd, Lydus Medical Ltd, Ovesco Endoscopy AG, Getinge AB, Olympus Medical Systems, Intuitive Surgical Inc, SurgiQuest Inc, AesDex LLC |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
